Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics, Erasmus Collaborate on Cancer and Congenital Malformations

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Complete Genomics today announced it is expanding a collaboration with Erasmus University Medical Center.

Under the expansion, the Mountain View, Calif.-based firm will sequence 250 DNA samples over the next 12 months. The samples will be from patients with leukemia and other cancers, as well as congenital malformations such as craniosynostosis.

The partners also are working together on other undisclosed projects, and as part of their collaboration, Complete Genomics has access to Erasmus MC's bioinformatics training center for customer training.

Additional expertise in technology and data management is being co-developed through partnerships with companies such as Ingenuity, Biobase, Tibco/Spotfire, Oracle, and VX Company.

Financial terms of the deal were not disclosed.

"We decided to focus our research efforts with Complete Genomics on diseases where the current technology has not been able to identify the genetic variants responsible," Peter J. van der Spek, head of bioinformatics at Erasmus MC, said in a statement. "Its complete human genome sequencing service will allow us to study genetic variations at a higher resolution and greater sensitivity than has been previously possible."

He added that it is expected that the collaboration will result in new methods and tools to improve patient stratification for targeted treatments.

Clifford Reid, CEO of Complete Genomics, said, "We hope that by furthering its understanding of the genetics of these complex diseases, Erasmus MC can be at the forefront of developing better diagnostic screens that form the basis for genetic testing in monogenetic diseases and targeted treatment development for diseases such as cancer."

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.